Description
Members of the Cambridge Biosafety Committee conduct oversight activities as granted under the Cambridge Recombinant DNA Technology Ordinance (Chapter 8.20) and the Cambridge Biosafety Regulation of 2009.
AGENDA
Introductions
Presentations
Cellular Ecosystem Therapeutics (Jennifer Michaelson) will request a new BSL-2 ONLY permit for their proposed facility at 215 First Street, 4th Floor
GlaxoSmithKlein (Chris Nolan, Chris Phelps) will request a new BSL-1/BSL-2 permit for their facility at 200 CambridgePark Drive
MRL (Stephen Schaub) will request an amendment to their BSL-1/BSL-2 permit to reflect changes of use and new expansion.
DoubleRainbow Biosciences (Jing-Ke Weng) will request a new BSL-2 ONLY permit for their proposed facility at 840 Memorial Drive, 1st floor.
Old Business/Site visits
Oct 2 – Kyn Therpaeutics (1030 Mass. Ave, 4th Floor) – walkthrough for new BSL-2 ONLY permit
Oct 11 – Merck Research Laboratory - MRL (320 Bent Street, 4th Floor) – walkthrough for relocation under current BSL-2 ONLY permit
Oct 12 – Aura Biosciences (85 Bolton Street) – walkthrough for relocation under current BSL-2 ONLY permit
New Business
Adjourn
MEETING SCHEDULE 2017-18 academic year (maintaining 3rd Thursday, 3:00 pm).
September 14 3:00 PM CHANGE OF DATE
October 26 3:00 PM CHANGE OF DATE
November 16 3:00 PM
December 21 3:00 PM
January 18 3:00 PM
February 15 3:00 PM
March 15 3:00 PM
April 19 3:00 PM
May 17 3:00 PM
June 21 3:00 PM